health

Alzheimer’s drugs ‘make no meaningful difference to patients’, say researchers

By
1 Mins read
53
0
Share
Reading Time: < 1 minute

Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s (Alamy/PA) -

Drugs that are said to slow the progression of Alzheimer’s disease “make no meaningful difference to patients” while increasing the risk of swelling and bleeding  Read More

53
0
Share
Related posts
health

Inmates 'forced to convert to Islam in UK prisons by gangs'

By
1 Mins read
Reading Time: < 1 minuteWhite prisoners are being forced to convert to Islam by Muslim gangs, reports say. New data from the Ministry of Justice (MoJ)…
health

Up to £464m moved through more than 3,000 UK high street shell companies

By
1 Mins read
Reading Time: < 1 minuteUp to £464m has “moved through” more than 3,000 UK shell companies branded as beauty and convenience stores but apparently operating in…
health

New warning for tenants as they face 'extremely steep' rent rises after rule change

By
1 Mins read
Reading Time: < 1 minute
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.